Main Management’s iShares US Medical Devices ETF IHI Stock Holding History

Main Management’s Portfolio IHI Stock Details IHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-317	Closed	-$18K	–	129
2024 Q4	$18K	Hold	317	–	–	﹤0.01%	115
2024 Q3	$19K	Hold	317	–	–	﹤0.01%	117
2024 Q2	$18K	Hold	317	–	–	﹤0.01%	123
2024 Q1	$19K	Sell	317 -286	-47%	-$16.2K	﹤0.01%	130
2023 Q4	$33K	Buy	603 +286	+90%	+$14K	﹤0.01%	107
2023 Q3	$15K	Hold	317	–	–	﹤0.01%	120
2023 Q2	$18K	Hold	317	–	–	﹤0.01%	115
2023 Q1	$17K	Buy	+317	New	+$16.9K	﹤0.01%	120

Other funds holding IHI

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Main Management's IHI Position: Q1 2025 in Review

Main Management sold out of iShares US Medical Devices ETF (IHI) in Q1 2025, closing a stake of 317 shares — an estimated $18K sold.

Main Management first reported a position in IHI in Q1 2023 and held it in 8 quarters. The position peaked at $33K in Q4 2023. 560 funds tracked by Wall St. Rank hold IHI as of Q1 2025.

Main Management reported no remaining iShares US Medical Devices ETF position as of Q1 2025 after selling out during the quarter.
Main Management sold 317 iShares US Medical Devices ETF shares in Q1 2025, an estimated $18K.
Main Management first reported a position in iShares US Medical Devices ETF in Q1 2023 and held it in 8 quarters.
Main Management's iShares US Medical Devices ETF position peaked at $33K in Q4 2023.
560 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q1 2025.

Based on Main Management's 13F filing for Q1 2025, filed 15 May 2025.